Notes
Slide Show
Outline
1
The Future of Quinacrine Sterilization:  India
  • Ashi R. Sarin.
  • Aastha Medical Center
  • Patiala-India
2
The All-India QS Experience
3
QS Ban in India-1
  •  QS study launched by ICMR in 1992 at Baroda and Chandigarh
  • Declared a failure due to 3 failures out of a total of 8 cases
4
QS Ban in India-2
  • 1997
  • A documentary ‘The Yellow Haze’ alleges coercion in a Delhi Medical College study leading to severe media criticism
5
QS Ban in India-3
  • QS ban comes into effect in March 1998 by a government notification   consequent to PIL by All-India Democratic Women’s Association and others


6
The Indian Scenario-1
  • India becomes a demographic billionaire on May 11, 2000
  • Population continues to grow at the rate of 2.1%
7
The Indian Scenario-2
  • Illiteracy
8
The Indian scenario - 3
  • Contraceptive practices
9
The Indian scenario - 4
  • A NFH Survey in 1993 showed 45% married women want no more children
10
The Indian scenario - 5
  • High MMR of 570/100,000
11
Overview of QS in India
  • 26,000 QS (worldwide total = 100,000)    done in India
  • Easy, inexpensive method
  • Proven safety and efficacy
  • Low risk/benefit ratio
12
Why QS in India?
  • Surgical method costly, impractical especially in rural India.
  • 1000 QS procedures can avert 10 maternal deaths
  • Annual female sterilizations = 6.05 million
  • Cost effective (<one dollar)
  • Estimated unmet contraceptive services = 28% : necessitating an additional expense of Rs 150 crores
  • QS can fulfil the unmet need


13
QS in Medical Conditions
  • Surgical sterilization/general anesthesia dangerous or contra indicated in severe anemia, heart disease, obesity, diabetes, COPD, etc.
  • QS offers a safer alternative in such conditions
14
QS in Patiala among high risk women

  • Patients
  • High risk for surgery : 92
  • Refused surgery out of
  • fear or voluntary choice : 27
  • Earlier failed surgery or
  • technical non-feasibility : 15
  • Total : 134
  • Follow-up : 7.2 years
  • Results : No failure or serious complication
  • Conclusion : Safe, effective,
  • non-surgical alternative


15
R.H.D, Mitral Stenosis
16
Laproligation and Minilap failure
17
Bronchial asthma
18
Laparoligation failure
19
Fear of surgery
20
Again laparoligation failure
21
Hypertension
22
Severe anemia
23
Conclusion
  • QS can fulfil the unmet need of female sterilization in private and public sectors
  • Safe, easy, efficient and cost-effective
  • Now India awaiting the results of  the US FDA trials
  • Frankly speaking the future of QS in India hangs on its fate in the US!